Changes of β-adrenergic signaling in compensated human cardiac hypertrophy depend on the underlying disease

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 6 47-6, 2000, Pages

  Schotten, Ulrich ^a   Filzmaier, Rarsten ^a   Borghardt, Britta ^a   Kulka, Simone ^a   Schoendube, Friedrich ^a   Schumacher, Carlos ^a   Hanrath, Peter ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Aortic valve stenosis; G proteins; Hypertrophic obstructive cardiomyopathy; Signal transduction; adrenoceptors

Indexed keywords

ADENYLATE CYCLASE; CYANOIODOPINDOLOL; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE;

ADRENERGIC SYSTEM; ADULT; AORTA VALVE STENOSIS; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

EID: 0033918683     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.6.h2076     Document Type: Article

References (41)

1. Boheler KR and Schwartz K. Gene expression in cardiac hypertrophy. Trends Cardiovasc Med 2: 176-182, 1992.
2. Böhm M, Castellano M, Agabiti RE, Flesch M, Paul M, and Erdmann E. Dose-dependent dissociation of ACE inhibitor effects on blood pressure, cardiac hypertrophy, and β-adrenergic signal transduction. Circulation 92: 3006-3013, 1995.
3. Böhm M, Ettelbrueck S, Flesch M, van Gilst W, Knorr A, Maack C, Pinto Y, Paul M, Teisman A, and Zolk O. β-Adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy. Cardiovasc Res 40: 146-155, 1998.
4. Böhm M, Gierschik P, Knorr A, Larisch K, Weismann K, and Erdmann E. Role of altered G-protein expression in the regulation of myocardial adenylate cyclase activity and force of contraction in spontaneous hypertensive cardiomyopathy in rats. J Hypertens 10: 1115-1128, 1992.
5. iα protein levels in patients with hypertensive cardiac hypertrophy, ischemic heart disease and cardiogenic shock. Cardiovasc Res 30: 611-618, 1995.
6. Böhm M, Kirchmayr R, Gierschik P, and Erdmann E. Increase of myocardial inhibitory G-proteins in catecholamine-refractory septic shock or in septic multiorgan failure. Am J Med 98: 183-186, 1995.
7. Böhm M, Moll M, Schmid B, Paul M, Ganten D, Castellano M, and Erdmann E. β-Adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats. Hypertension 24: 653-662, 1994.
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
9. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, and Stinson EB. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med 307: 205-211, 1982.
10. Bristow MR, Kantrowitz NE, Ginsburg R, and Fowler MB. β-Adrenergic function in heart muscle disease and heart failure. J Mol Cell Cardiol 17 Suppl 2: 41-52, 1985.
11. Brodde OE. Pathophysiology of the β-adrenoceptor system in chronic heart failure: consequences for treatment with agonists, partial agonists or antagonists? Eur Heart J 12 Suppl F: 54-62, 1991.
12. 125I]iodocyanopindolol binding. Circ Res 53: 752-758, 1983.
13. Brush JEJ, Eisenhofer G, Garty M, Stull R, Maron BJ, Cannon RO, Panza JA, Epstein SE, and Goldstein DS. Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. Circulation 79: 836-844, 1989.
14. Castellano M, and Böhm M. The cardiac β-adrenoceptor-mediated signaling pathway and its alterations in hypertensive heart disease. Hypertension 29: 715-722, 1997.
15. Cech S, Broaddus W, and Maguire M. Adenylate cyclase: the role of magnesium and other divalent cations. Mol Cell Biochem 33: 67-92, 1980.
16. Davis GC, Kissinger PT, and Shoup RE. Strategies for determination of serum or plasma norepinephrine by reversephase liquid chromatography. Anal Chem 53: 156-159, 1981.
17. 2-adrenoceptors. Eur J Pharmacol 130: 137-139, 1986.
18. Feldman AM. Modulation of adrenergic receptors and G-transduction proteins in failing human ventricular myocardium. Circulation 87: IV27-IV34, 1993.
19. Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, Baumgartner WA, and Van Dop C. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest 82: 189-197, 1988.
20. Flesch M, Erdmann E and Böhm M. Changes in β-adrenoceptors and G-proteins during the transition from cardiac hypertrophy to heart failure. J Card Fail 2: S35-S43, 1996.
21. Galinier M, Senard JM, Valet P, Arias A, Daviaud D, Glock Y, Bounhoure JP, and Montastruc JL. Cardiac β-adrenoceptors and adenylyl cyclase activity in human left ventricular hypertrophy due to pressure overload. Fundam Clin Pharmacol 8: 90-99, 1994.
22. Goldsmith P, Gierschik P, Milligan G, Unson CG, Vinitsky R, Malech HL, and Spiegel AM. Antibodies directed against synthetic peptides distinguish between GTP-binding proteins in neutrophil and brain. J Biol Chem 262: 14683-14688, 1987.
23. i3 complementary DNA. J Biol Chem 263: 6476-6479, 1988.
24. Golf S, Myhre E, Abdelnoor M, Andersen D, and Hansson V. Hypertrophic cardiomyopathy characterised by β-adrenoceptor density, relative amount of β-adrenoceptor subtypes and adenyl ate cyclase activity. Cardiovasc Res 19: 693-699, 1985.
25. Kawai C, Yui Y, Hoshino T, Sasayama S, and Matsumori A. Myocardial catecholamines in hypertrophic and dilated (congestive) cardiomyopathy: a biopsy study. J Am Coll Cardiol 2: 834-840, 1983.
26. Keller R, Oke A, Mefford I, and Adams RN. Liquid Chromatographic analysis of catecholamines: routine assay for regional brain mapping. Life Sci 19: 995-1003, 1976.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
28. Lefroy DC, De SR, Choudhury L, Uren NG, Crake T, Rhodes CG, Lammertsma AA, Boyd H, Patsalos PN, and Nihoyannopoulos P. Diffuse reduction of myocardial β-adrenoceptors in hypertrophic cardiomyopathy: a study with positron emission tomography. J Am Coll Cardiol 22: 1653-1660, 1993.
29. Messmer BJ. Extended myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 58: 575-577, 1994.
30. 2-adrenoceptor function in human heart failure. Br J Clin Pharmacol 30 Suppl 1: 37S-42S, 1990.
31. i proteins in heart failure. Lancet 2: 936-937, 1988.
32. Post S, Hilal DR, Urasawa K, Brunton L, and Insel PA. Quantification of signaling components and amplification in the β-adrenergic-receptor-adenylate cyclase pathway in isolated adult rat ventricular myocytes. Biochem J 311: 75-80, 1995.
33. Purjeranta M, Rechardt L, Pelto HM, and Kyösola K. Light and electron microscopic demonstration of neuropeptide Y-like immunoreactive nerves in human cardiac muscle. Virchows Arch 410: 147-151, 1986.
34. Salomon Y, Londos C, and Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem 58: 541-548, 1974.
35. Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 660-672, 1949.
36. 2+-ATPase protein expression in compensated primary and secondary cardiac hypertrophy. J Mol Cell Cardiol 31: 1483-1494, 1999.
37. Schotten U, Schumacher C, Koenigs B, Hense M, Schoendube FA, and Hanrath P. Increased inhibitory G protein level rather than β-adrenoceptor downregulation determines catecholamine refractoriness in human hypertrophied myocardium (Abstract). J Mol Med 76: B29, 1998.
38. Schumacher C, Becker H, Conrads R, Schotten U, Pott S, Kellinghaus M, Sigmund M, Schondube F, Preusse C, Schulte HD, and Hanrath P. Hypertrophic cardiomyopathy: a desensitized cardiac β-adrenergic system in the presence of normal plasma catecholamine concentrations. Naunyn Schmiedebergs Arch Pharmacol 351: 398-407, 1995.
39. s carboxyl-terminal decapeptide. FEBS Lett 249: 189-194, 1989.
40. 2-adrenoceptors in different human heart diseases. Naunyn Schmiedebergs Arch Pharmacol 343: 217-220, 1991.
41. Towbin H, Staehelin T, and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.